Synteract, an innovative CRO partnering with biotech and pharma companies to bring new medicines to market, has acquired Clindata’s human health biometrics division to meet market demand for more adaptable biometrics services solutions. This acquisition extends Synteract’s existing global footprint into Asia Pacific and Africa, and offers another core biometrics services hub, complementary to those it operates in Europe and the U.S. Clindata, with offices in Bloemfontein, South Africa, and Colombo, Sri Lanka, is a biometrics Clinical Research Organization, offering biostatistics, programming and data management services across all phases of drug development. Clindata’s Veterinary division will continue to operate under the Clindata name, independently from Synteract, while the Human Health Biometrics division will combine with Synteract. Synteract is a portfolio company of Amulet Capital Partners, LP.
Read the full article: Synteract Expands into Asia Pacific and South Africa through Acquisition of Specialty Biometrics CRO //
Source: https://www.businesswire.com/news/home/20200204005231/en/Synteract-Expands-Asia-Pacific-South-Africa-Acquisition